A novel vascularized hydrogel by encapsulation of lyophilized platelet-rich fibrin into gelatin methacryloyl hydrogel for bone regeneration Authors: Xiongjie Huang, Songlin Xie, Changxiong Liu, Xiangjun Xiao, Huiyu Tang, Yunhua Xu, Junfang Wang, Zhixiang He, JiuSong Wang, Biao Hou, Jun Zhang, Mingjiang Liu Published: 2025 ABSTRACT AbstractVascularized osteogenesis is crucial for bone regeneration. Platelet-rich fibrin (PRF) includs many growth factors, of which VEGF plays the significant role in vascularization. No study has investigated the effect of lyophilized platelet-rich fibrin (Ly-PRF) combined with gelatin methacryloyl (GelMA) on the repair of bone defects. We first prepared fresh PRF by one-step centrifugation method. Then, we constructed Ly-PRF by lyophilization. Afterwards, GelMA was synthesized by chemical synthesis method and GelMA hydrogel was prepared by photo-crosslinking method. Finally, Ly-PRF was encapsulated into GelMA hydrogel to construct GelMA@Ly-PRF hydrogel and used in vitro and in vivo to explore its effect on calvarial regeneration of rats. The fresh PRF had good elasticity. GelMA was synthesized by chemical synthesis method and GelMA hydrogel was formed by blue light-irradiation of GelMA solution. After encapsulation of Ly-PRF into GelMA hydrogel, VEGF in Ly-PRF could slowly and sustainably release for continuous 21 days. In vitro, the GelMA@Ly-PRF hydrogel had high swelling property and porous structure. What’s more, it had good cytocompatibility and was capable of promoting angiopoiesis of human umbilical vein endothelial cells (HUVECs). In vivo, the GelMA@Ly-PRF hydrogel could facilitate to repair calvarial defects of rats by promoting formation of new blood vessel during the process of bone healing, evidenced by Micro-CT, H&E staining, Masson’s staining and immunohistochemical staining of CD31 and OPN. Encapsulation of Ly-PRF into a GelMA hydrogel could promote bone regeneration of rats. Introduction Large bone defects caused by trauma, infection or tumor resection are common diseases in clinic and the effective reconstruction of large bone defects still remain challenging in orthopedic surgery [1, 2]. As we all konw, bone tissue is the highly vascularized tissue and vascularization plays the significant role in supporting local tissue survive, rescue, and repairing [3, 4]. Therefore, it is important to realize neovascularization for large bone defects. Currently, many kinds of vascularization strategies have been utilized by manipulating the factors involving in physiological angiogenesis to promote bone regeneration, including hypoxia, vascular cells, scaffold materials and growth factors [5–10]. Among them, angiogenic growth factors have attracted many researchers’ attention and have been widely utilized to induce neovascularization, which can endow the enhanced vascularized microenvironment for bone formation [11, 12]. However, direct injection or application of angiogenic growth factors in local bone defects has some problems. For instance, short half-life and side effect of high dose application growth factors [13–15]. Therefore, an effective and safe delivery system is indispensable to overcome the disadvantages of direct application of angiogenic growth factors. In recent years, various engineering methods have been developed to achieve sustained and safe release of angiogenic growth factors during tissue healing, including affinity tethering, chemical immobilization, physical entrapment and so on [16, 17]. Although these delivery systems can mimick the sustained and controlled release kinetics in vivo, their efficacies are easily decreased by the stability issue or specifc loading processes during the course of delivery. For example, the study performed by Zhu et al. demonstrated that more than 90% of protein that loaded in microspheres lost the bioactivity because of the agglomeration caused by acidic pH [16]. In addition, supraphysiological dosages for growth factors are probably responsible for severe side effects [17]. Therefore, novel angiogenic strategies that are capable of offering precise controllability and maintaining the high bioactivity are considerably urgent for bone regeneration. Platelet-rich fibrin (PRF), a second generation of platelet concentrate extracted from whole blood, has been widely used in tissue repair [18]. Compared with the first generation of platelet concentrate (platelet-rich plasma, PRP), the preparation process of PRF is relatively simple (only one centrifugation) and need not additional addition bovine thrombin and anticoagulant, which can effectively avoid the risk of rejection reaction as well as coagulation disorders [19–21]. Previous studies have indicated that PRF contained high concentrations of growth factors, including platelet-derived growth factor (PDGF), insulin-like growth factor (IGF), bone morphogenetic protein-2 (BMP-2), transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF), among which VEGF played an essential role in promoting angiogenesis and could facilitate bone healing process [22–24]. In addition, the unique honeycomb-like microstructure of PRF entraps platelets, which results in the steady release of growth factors from PRF for a sustained period [25, 26]. Therefore, it is promising for bone regeneration by using PRF for sustained release VEGF to promote angiogenesis. However, PRF has poor resistance to stretching or compression and lacks stabilized shape, which hinder its wide application in clinic. Lyophilization is a universally utilized technique to prepare platelets as well as proteins [27]. By using this technique, lyophilized platelet-rich fi brin (Ly-PRF) has been successfully prepared, which has the advantage of lowing the diffculty in application. Previous studies revealed Ly-PRF was capable of sustainably releasing growth factors, which provided straightforward access to growth factors for newly grown tissue [27–29]. Hydrogels have been widely used in regenerative medicine because of their advantages for providing suitable 3D microenvironment for cells growth, carrying cells to damaged sites and delivering various growth factors [30, 31]. The water-laden matrice of hydrogels have been proved to support cellular adhesion and functionality, and facilitate angiogenesis due to the increasement half-lives of growth factors in vivo [32]. Gelatin methacryloyl (GelMA), a photosensitive hydrogel, has been extensively used in tissue engineering applications because of its good biocompatibility, biodegradability as well as tunable physicochemical properties [33]. It is easy to adjust the chemical properties of GelMA by regulating the ratio of merhacryloyl and gelatin. The tailorable mechanical properties of GelMA can be realized during the process. What’s more, GelMA is capable of in situ gelation following injection or 3D printing into complex anatomical structures due to its photo-crosslinkable nature [33, 34]. In recent years, GelMA has been widely used as a biomaterial to facilitate bone regeneration [35, 36]. In this study, we delivered GelMA incorporated with Ly-PRF into the calvarial defects of rats. GelMA provided a 3D microenvironment for cells growth as well as protected the inner growth factors of Ly-PRF from inactivation, while the Ly-PRF served as a platform for controlled release of growth factor (VEGF) for promoting angiogenesis and accelerating bone regeneration. Therefore, we developed a novel therapeutic strategy that could sustainedly release of growth factor (VEGF) for realizing neovascularization, which had the potential to transformational application in clinic (Fig. 1). Preparation process of GelMA@Ly-PRF hydrogel and detection the effect on promoting bone regeneration Materials and methods GelMA synthesis GelMA was synthesized in accordance with the method that reported in the previous study [36]. Briefly, 10 g gelatin was completely dissolved into 100 mL phosphate buffer solution (PBS) at 60 °C. Then, 8 mL methacrylic anhydride (MA) was added into gelatin solution with a microinjection pump at the rate of 0.25 mL/min. This process should avoid light. The reaction was maintaining for 2 h at 60 °C and the reaction was stopped by supplementing additional preheated PBS to the solution. Afterwards, the solution was stirred at 60 °C for 15 min and the resulting solution was dialyzed in distilled water with a dialysis bag for 7 days. Then, the purifed GelMA solution was freeze-dried and stored at −80 °Cfor long-term storage and further use. Preparation and characterization of GelMA hydrogel GelMA was dissolved in deionized water to obtain a 5% solution. Then, LAP was added to the solution at a final concentration of 0.1%. The GelMA hydrogel was finally formed by blue light (405 nm) irradiation for 30 s (Irradiance: 15 mW/cm²). The preparation process of GelMA solution was shown in Fig. 2. Then, scanning electron microscope (SEM) was used to observe the microstructure of GelMA hydrogel. In brief, GelMA hydrogel was fixed using 3% glutaraldehyde, followed by fixing in 1% osmium tetroxide and dehydration. Then, GelMA hydrogel was air dried, mounted, sputter coated with gold, and tested using the Hitachi SU8100 SEM (Hitachi, Tokyo, Japan). GelMA synthesis and preparation of GelMA hydrogel. A Chemical reaction for the preparation of GelMA. B GelMA could be uniformly dissolved in PBS. C, D Preparation of GelMA hydrogel by irradiating GelMA solution with blue light Preparation of fresh PRF and Ly-PRF The PRF was prepared according to the previous protocol [20]. In brief, 10 mL of whole blood was harvested from rats and poured into sterile glass tube without any anticoagulant. Afterwards, the harvested whole blood was immediately centrifuged at 500 × g for 10 min at 4 °C (using a centrifuge with a rotor radius of 8.5 cm), and the fresh PRF was harvested and located in the middle layer of the glass tube. Then, the fresh PRF was easily separated from the red corpuscles at the bottom and used in subsequent detection. The morphology of the fresh PRF was detected by digital camera (CANON, Japan). For preparation of Ly-PRF, the fresh PRF was freeze-dried with a Labconco lyophilizer for 12 h. Then, SEM was performed to observe the microstructure of Ly-PRF. Characterization of GelMA@Ly-PRF hydrogel SEM detection The morphology of the GelMA hydrogel with Ly-PRF was viewed by SEM. In brief, GelMA hydrogel with Ly-PRF was fixed using 3% glutaraldehyde, followed by fixing in 1% osmium tetroxide and dehydration. Then, GelMA hydrogel with Ly-PRF was air dried, mounted, sputter coated with gold, and tested using the Hitachi SU8100 SEM (Hitachi, Tokyo, Japan). Swelling property For the swelling test of GelMA hydrogel with or without Ly-PRF, lyophilized hydrogels (W1) were immersed in deionized water at 37 °C. The pH of the suspension was adjusted to 7.4. At defined time points, the swollen hydrogels (W2) were taken out and the excess water on the surface of hydrogels were wiped with filter paper before weighting the hydrogels. The whole procedure was repeated until a constant weight was obtained. The swelling ratio (SR)was calculated with the following formula: SR = (W2 − W1)/W1. Growth factor release experiment The growth factor release experiment was tested by ELISA. Briefly, 100 μL of GelMA hydrogel incorporating Ly-PRF derived from 1 mL whole blood were incubated in 1 ml PBS at 37 °C with shaking. At the expected time points, the supernatant was collected and then 1 mL of fresh PBS was added at each time point. The concentration of VEGF in the collected supernatant was determined using an rat VEGF ELISA kit, and the release amount and cumulative release rate at each time point were calculated. Biocompatibility of GelMA@Ly-PRF hydrogel In this study, we used human umbilical vein endothelial cells (HUVECs) and bone marrow mesenchymal stem cells (BMSCs) to detect the biocompatibility of GelMA@Ly-PRF. Firstly, we prepared the extractive of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel by soaking GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel in 10 mL DMEM/F-12 medium containing 10% FBS and 1% penicillin/streptomycin in a centrifuge tube for 24 h. Then, HUVECs and BMSCs (1.0 × 104 cells/well) were seeded into well plates and incubated for 24 h, respectively. Afterwards, Calcein AM/PI detection working solution was added to assess the viability of HUVECs and BMSCs. In addition, CCK-8 assay was used to assess the proliferation of HUVECs and BMSCs treated with GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. Phalloidin staining Phalloidin staining was further carried out to observe the cytoskeletons of BMSCs co-cultured with GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. Briefly, BMSCs were seeded into 24 well plates at a density of 2 × 104 cells per well. Then, the extractive of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel were added to co-culture with BMSCs. The medium was discarded and BMSCs were washed with PBS after 48 h of co-culture. Afterwards, BMSCs were fixed at room temperature for 10 min and 0.2% Triton X-100 was added to each well. After 2% BSA was added for 30 min, phalloidin staining solution was added to each well and stained at room temperature for 40 min. Finally, cell nuclei was stained by DAPI solution and BMSCs were observed under fluorescence microscope. Angiogenic assay To evaluate the capability of VEGF released from the GelMA@Ly-PRF hydrogel for promoting angiogenesis, matrigel (100 µL/well) (Corning, USA) was gelled in 24-well culture plate to induce tube formation. Then, HUVECs were seeded in each well at a concentration of 5 × 104 cells/ml. The seeded HUVECs were subjected to three different conditions: extractive of GelMA extractive, extractive of Ly-PRF and extractive of GelMA@Ly-PRF extractive. The culture plate was incubated at 37 °C with 5% CO2. At sixth hours after culture, the culture plate was washed three times with PBS. Afterwards, HUVECs were stained with Calcein AM detection working solution and the labeled HUVECs were photographed by fluorescence microscope. The tubular number of junctions, number of nodes and tubular length were quantified to asess the tube formation ability via Image J software. In vivo experiment The animal experiment in this study was approved by the Ethics Committee of Nanhua Hospital University of South China [2024-KY-012]. In this study, calvarial defects were created in a total of 16 Male Sprague-Dawley rats (SD, approximate weight of 300–350 g). All procedures were performed as described in the previous article [27]. Briefly, surgery was performed with anesthesia administered via intraperitoneal injection of 2% sodium pentobarbital. Then, a longitudinal incision was made in the middle of the surgical area after shaving and sterilizing. Whereafter, two bilateral bone defects with 4 mm in diameter were made on calvarium of rats by a dental trephine. The experiment was divided into 4 groups: group A, control group (defects were filled with nothing); group B, GelMA group (defects were filled with GelMA hydrogel); group C, Ly-PRF group (defects were filled with Ly-PRF); group D, GelMA@Ly-PRF group (defects were filled with GelMA@Ly-PRF hydrogel). After surgery, penicillin was injected for continuous three days to prevent infection. All rats were sacrificed at 8 weeks, and calvarial specimens were harvested for further assessments. After 8 weeks of operation, all rats were euthanatized and the calvarial specimens were harvested and fixed in 4% paraformaldehyde for further characterization. Micro-CT was firstly performed to assess the regenerative condition of different treatments. Then, the calvarial specimens were decalcified for about 2 weeks, followed by alcohol gradient dehydration and embedding in paraffin block. Afterwards, they were embedded in paraffin for histological sectioning. The embedded specimens were cut into 5-µm-thick histological sections across the center of the defect area and sujected to H&E staining and Masson’s staining. Meanwhile, CD31 and OPN immunohistochemical staining were used to evaluate the formation of blood vessel and the new bone formation, respectively. Statistical analysis The data are expressed as the mean ± standard deviation. One-way ANOVA was used, followed by Tukey’s multiple comparison test for further evaluation of the differences between the groups. P < 0.05 was considered statistically significant. Results GelMA synthesis and preparation of GelMA hydrogel In the current study, the chemical reaction for preparation of GelMA was shown in Fig. 2A. The synthesized GelMA was white loose texture, which could be uniformly dissolved in PBS due to the the hydrophilic characteristic of GelMA (Fig. 2B, C). Under blue light, the GelMA solution could be crosslinked to form GelMA hydrogel (Fig. 2D). These results above indicated that GelMA was successfully synthesized and GelMA hydrogel was prepared by blue light irradiation of GelMA solution. Preparation and characterization of fresh PRF and Ly-PRF The fresh PRF and Ly-PRF were prepared and formed with the method described previously [20]. The preparation process of fresh PRF and Ly-PRF was shown in Fig. 3A. The fresh PRF was located in the middle of the glass tube after centrifugation. As shown in Fig. 3A, B, the platelet-poor plasma was at the top of fresh PRF and red blood cells were at the bottom of the glass tube. We harvested intact PRF with scissors and forceps. The fresh PRF had good elasticity and could be made into patche with mechanical force (Fig. 3B). Then, the fresh PRF was freeze-dried to form freeze-dried Ly-PRF. The macrophotograph of fresh Ly-PRF was presented as shown in Fig. 3B. The result of SEM showed that the Ly-PRF had the honeycomb-like porous structure (Fig. 3C). Preparation and characterization of fresh PRF and Ly-PRF. A The preparation process of fresh PRF and Ly-PRF. B The macrophotograph of Ly-PRF. C SEM result of Ly-PRF Characterization of GelMA@Ly-PRF hydrogel SEM detection SEM revealed that GelMA hydrogel had a porous and sponge-like microstructure, which not only provided a good basis for Ly-PRF loading but also facilitated growth factors release from Ly-PRF (Fig. 4A). In addition, the results of SEM showed that GelMA@Ly-PRF hydrogel also had a porous microstructure, which indicated that encapsulating Ly-PRF into GelMA hydrogel did not change its original structure (Fig. 4B). The above SEM results demonstrated that we successfully synthesized GelMA@Ly-PRF with a porous microstructure. Typical SEM images of GelMA hydrogel and GelMA@Ly-PRF hydrogel with different magnifcations. A Typical SEM images of GelMA hydrogel with different magnifcations. B Typical SEM images of GelMA@Ly-PRF hydrogel with different magnifcations Swelling property As we all know, the high swelling ratio of hydrogel is the crucial property for drug or growth factors loading and release. Therefore, we performed the swelling ratio of GelMA hydrogel with or without Ly-PRF. As shown in Fig. 5, GelMA hydrogel and GelMA@Ly-PRF both exhibited the obvious increase in swelling ratios within the first 2 h, and then the swelling ratios of them remained almost constant for 12 h. These results demonstrated that these two hydrogels reached the swelling equilibrium within less than 2 h and some amount of water could be retained with the hydrogel structures. Besides, there was no obvious difference between GelMA hydrogel and GelMA@Ly-PRF hydrogel, which indicated that encapsulation Ly-PRF into GelMA hydrogel could not influence its swelling ratio. The swelling ratio of GelMA and GelMA@Ly-PRF. The swelling ratio of GelMA hydrogel and GelMA@Ly-PRF exhibited the obvious increase in within the first 2 h, and then the swelling ratios of them remain almost constant for 12 h Growth factor release experiment Although some growth factors had a significant role in vascularization and therefore could promote bone regeneration, short half-life period in vivo hindered their wide application. Therefore, we encapsulated Ly-PRF into GelMA hydrogel to realize the controlled and prolonged release of VEGF, which facilitated angiopoiesis and promoted bone regeneration. The cumulative release profiles from GelMA@Ly-PRF hydrogel showed a rapid release in the first 3 days and followed by a sustained release period of up to 21 days (Fig. 6). The cumulative release of VEGF from GelMA@Ly-PRF hydrogel. VEGF from GelMA@Ly-PRF hydrogel showed a rapid release in the first 3 days and could sustainedly release for 21 days Biocompatibility of GelMA@Ly-PRF hydrogel The good biocompatibility of biomaterials is the prerequisite for application in vivo. Therefore, live/dead staining and CCK-8 detection were carried out to detect the biocompatibility of GelMA@Ly-PRF hydrogel. There was no significant difference in the results of live/dead staining of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. As shown in Fig. 7, live cell numbers (green) of HUVECs increased with increasing culture time in all groups, which illustrated the good biocompatibility and non-toxicity of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. CCK-8 results also demonstrated that HUVECs continuously proliferated with increasing culture time, indicating GelMA hydrogel Ly-PRF and GelMA@Ly-PRF hydrogel did not have cytotoxicity (Fig. 7). Biocompatibility of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel on HUVECs. A Live/Dead staining assay of HUVECs cells cocultured with GelMA, Ly-PRF and GelMA@Ly-PRF. B Quantitative analysis of live cells in live/dead assays. C The CCK-8 results on 1, 2, and 3 days. OD: optical density In addition, we also detected the cytocompatibility of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel on BMSCs. As shown in Fig. 8, the results of live/dead cell staining and CCK-8 assay indicated that BMSCs in all groups increased with the extension of culture time, and no significant difference was observed in the number of live cells in all groups at day 1, 2 and 3, which demonstrated that GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel had no toxicity to BMSCs. These results above both demonstrated that GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel neither affected cell activity nor hindered cell growth and proliferation, which ensured that the GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel had good biocompatibility for in vivo experiments. Biocompatibility of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel on BMSCs. A Live/Dead staining assay of BMSCs cocultured with GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. B Quantitative analysis of live cells in live/dead assays. C The CCK-8 results on 1, 2, and 3 days. OD optical density Further, phalloidin staining was carried out to observe cytoskeletons of BMSCs co-cultured with GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. As shown in Fig. 9, all BMSCs showed the good cellular morphologies, which also demonstrated that GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel all had no toxicity to BMSCs. Phalloidin staining. BMSCs co-cultured with GelMA hydrogel, Ly-PRF hydrogel and GelMA@Ly-PRF hydrogel were subjected to phalloidin staining Angiogenic assay The ability of hydrogel to induce vascular formation plays a crucial role in bone regeneration as it is capable of providing blood supply that delivered oxygen as well as nutrients to the impaired bone defects. Therefore, the effect of GelMA@Ly-PRF hydrogel on vessel-forming capability was assessed by a matrigel tube formation assay. We could observe more vascular tube was formed in GelMA@Ly-PRF hydrogel group compared with that GelMA hydrogel group and the Ly-PRF group. Besides, we could draw the similar conclusions in the tubular number of junctions, number of nodes and tubular length in each group by Image J analysis (Fig. 10). These results revealed that GelMA@Ly-PRF hydrogel could enhance angiogenesis of HUVECs in vitro. The underlying mechanism was that the VEGF contained in Ly-PRF played an important role in promoting angiogenesis of HUVECs Fig. 10. Angiogenesis assay of HUVECs treated with extracts of GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel. A HUVECs were stained with Calcein AM. B–D Quantitative analysis of the tubular number of junctions, number of nodes and tubular length in each group of vascular tube formation ($ and * indicated p < 0.05 in comparison with the control group and GelMA@Ly-PRF group) In vivo experiment Micro-CT To assess the regeneration of bone defects, rat calvarial bone defect model was introduced, and GelMA hydrogel, Ly-PRF and GelMA@Ly-PRF hydrogel were implanted into calvarial defects. 8 weeks postoperation, we first took micro-CT analysis to assess the new bone formation at the bone defect area. We could observe that new bone tissues gradually invaded bone defects in all groups. The bone gaps in the GelMA@Ly-PRF hydrogel group were smaller than those in the GelMA hydrogel group, the Ly-PRF group and the control group. Only a small amount of bone was found in the defect area in the control group, while a substantial amount of newborn bone tissue was formed in the GelMA@Ly-PRF hydrogel group (Fig. 11A). What’s more, the newly formed bone was almost completely filled the bone defects, indicating that synergistic effect of the GelMA@Ly-PRF hydrogel on bone regeneration (Fig. 11A). The quantitative analysis of new bone formation was performed and bone volume fraction (BV/TV), bone mineral density (BMD), trabecular thickness (Tb.Th) and trabecular number (Tb.N) were analysed to evaluate the bone repairing effect, which further substantiated the gross observations. After 8 weeks of the surgery, the results of BV/TV revealed the value of the GelMA@Ly-PRF hydrogel group was signifcantly higher than that of the other groups. Besides,the value of the GelMA hydrogel and Ly-PRF was higher than the control group. Likewise, the BMD, Tb.Th and Tb.N of the GelMA@Ly-PRF hydrogel group were signifcantly higher than these of other groups (Fig. 11B). These results demonstrated that the formation of new bone tissue was effective in the GelMA@Ly-PRF hydrogel group and GelMA@Ly-PRF hydrogel had better effect on bone regeneration. Micro-CT analysis of in vivo performance at 8 week. A Typical 3D reconstruction images of bone defect areas at 8 week. B Bone volume fraction (BV/TV), Bone mineral density (BMD), Trabecular number (Tb.N) and Trabecular thickness (Tb.Th) (# and * indicated p < 0.05 in comparison with the control group and GelMA@Ly-PRF group) Histological evaluation Histological evaluation of H&E staining and Masson’s staining was performed to further assess the effcacy of GelMA@Ly-PRF hydrogel in accelerating calvarial defect repair at 8 weeks after the operation. H&E staining results showed that much denser bony tissues in the GelMA@Ly-PRF hydrogel group than in the other groups and a high amount of bone matrix was observed in the GelMA@Ly-PRF hydrogel group, which demonstrated signifcant bone regeneration 8 weeks postoperation. Conversely, the GelMA hydrogel group, the Ly-PRF group and the control group showed little new bone and the defects were primarily filled with fibrous tissue 8 weeks after operation, which demonstrated the inferior bone regenerative capacity (Fig. 12A). Masson’s staining also showed the similar trend between the GelMA@Ly-PRF hydrogel group and other groups 8 weeks after operation (Fig. 12B). As we all know, the mature collagen and calcifed bone presented red color under Masson’s staining. As shown in Fig. 12B, we could observe more mature collagen and calcifed bone formed at the center of the bone defect in the GelMA@Ly-PRF hydrogel group, which indicated that the new bone was gradually calcifed and matured. However, less osteoid formation was found in the control group. Histological analysis in vivo. A Representative H&E staining images at 8 week after operation with different magnifcation. B Representative Masson’s staining images at 8 week after operation with different magnifcation As we all know, vascularization and osteoinduction are two crucial processes for bone regeneration [37]. Therefore, CD-31 and OPN immunohistochemical staining was performed to evaluate the vascularization and osteoinduction in vivo. The results of IHC staining showed strongly positive in the GelMA@Ly-PRF hydrogel group, which indicated the vascularization and new bome formation (Fig. 13). Immunohistochemical staining and quantitative analysis of OPN and CD-31. A OPN immunohistochemical staining at 8 weeks after operation; B CD-31 immunohistochemical staining at 8 weeks after operation; C Quantitative analysis of relative positive area of OPN; D Quantitative analysis of relative positive area of CD-31 (# and * indicated p < 0.05 in comparison with the control group and GelMA@Ly-PRF group) Discussion In this study, we investigated the feasibility of repairing calvarial defects by using GelMA hydrogel encapsulated with Ly-PRF. In vitro, we successfully prepared fresh PRF by one-step centrifugation. In addition, the fresh PRF was freeze-dried to prepare Ly-PRF. Afterwards, we prepared GelMA hydrogel and encapsulated Ly-PRF into GelMA hydrogel, and the characterization of GelMA@Ly-PRF hydrogel was evaluated by SEM, swelling property, growth factor release experiment, live/dead staining, CCK-8 assay and phalloidin staining. In vivo, we demonstrated that GelMA @Ly-PRF hydrogel had a better effect on bone regeneration than GelMA hydrogel or Ly-PRF alone, as evidenced by micro-CT and histological evaluation. Although the potential mechanisms of this treatment have not been elucidated, the results showed that GelMA@Ly-PRF hydrogel played important roles in bone regeneration. It is the first study to utilize GelMA@Ly-PRF hydrogel to promote the healing process of bone regeneration. Large bone defects are still huge challenge for orthopedic surgeons [38]. Although current treatments (such as: autogenous, allogenic and artificial bone graft transplantation) have achieved some good outcomes, 5% to 10% of patients will suffer from delayed fracture healing or even non-healing, bringing huge economic burden to patients as well as the society [39]. In the recent years, various tissue-engineered bone have been developed to utilize for the treatment of large bone defects [40–42]. However, most of these tissue-engineered bone have focused on the bone defect itself, whlie neglected the importance of the vascularization. To our best knowledge, bone tissue is a highly vascularized tissue and the formation of new blood vessels in the bone defects is an effective therapy to restore blood and nutrient supply for bone regeneration [43, 44]. Therefore, how to realize the vascularization in the bone defects is the crucial factor for bone regeneration. In this study, we used PRF as a reservoir for sustainable supply various growth factors for bone regeneration, especially VEGF that played a pivotal part in revascularization. Many studies have demonstrated that PRF contained various growth factors, including PDGF, IGF, TGF-β, BMP-2 and VEGF [37]. What’s more, VEGF in PRF has been verified the critical factor for promoting bone regeneration. PRF as a novel generation of platelet concentrate product has many advantages compared with PRP [37]. For instance, PRF contains more abundant growth factors than PRP. In addition, PRF can effectively avoid the risk of rejection reaction and coagulation disorders because it needs not addition of biochemical additives during the preparation process. Last but no least, PRF is capable of providing more longer-term and effective release of various growth factors than PRP. Nevertheless, PRF lacks stable shape and resistance to compression or stretching, which limits the further application in clinic. Lyophilization is a universally utilized technique to prepare platelets as well as proteins [17]. Therefore, we used this technique to prepare Ly-PRF to overcome the limitations of fresh PRF. Various synthetic or natural hydrogels have been extensively used in tissue engineering regenerative medicine [45–48]. For bone regeneration, GelMA hydrogel is one of the widely used hydrogels. Xin et al. made a new GelMA modified MBGNs to promote the stability of GelMA hydrogel and they demonstrated that the GelMA-G-MBGN hydrogel could enhance the angiogenesis and osteogenesis of bone reconstruction [35]. Xin et al. prepared a kind of MBGNs grafted with rhBMP-2 and mixed with GelMA to imitate the periosteum structure for promoting bone reconstruction [36]. Therefore, we used GelMA hydrogel incorporated with Ly-PRF to promote bone regeneration in this study. In vitro, we first prepared the fresh PRF by one step centrifugation and SEM results demonstrated that the fresh PRF had honeycomb-like porous structure. Then, lyophilization was utilized to prepare Ly-PRF. Afterwards, we prepared a novel vascularized hydrogel by encapsulating of Ly-PRF into a GelMA hydrogel. This GelMA@Ly-PRF hydrogel had high swelling property, excellent mechanical property and porous structure. What’s more, GelMA@Ly-PRF hydrogel had good cytocompatibility and was capable of promoting angiopoiesis. In vivo, rat calvarial defect model was introduced to asess the effect of the novel vascularized hydrogel on bone regeneration. The results demonstrated that the GelMA@Ly-PRF hydrogel could facilitate to repair calvarial defects of rats by promoting formation of new blood vessel during the process of bone healing, evidenced by Micro-CT, H&E staining and Masson’s staining and immunohistochemical staining of CD31 and OPN. This study also had some limitations. Firstly, we only detected one growth factor (VEGF) and explored its effect on vascularization and bone regeneration. In the future studies, more growth factors should be detected and their mutual impact need to be illustrated. Secondly, the potential molecular mechanisms underlying the angiopoiesis and bone regeneration effect of Ly-PRF still remain unknown. Further studies are required to focus on signaling pathways associated with possible molecular mechanisms of Ly-PRF. Thirdly, the therapeutic effects of GelMA@Ly-PRF hydrogel were evaluated only eight weeks post transplantation. Therefore, future studies concentrating on multiple time pionts and longer time points are needed because of the gradual process of bone healing. Lastly, the rat model was used in this study, which was different from humans in physiological conditions. So, further large animal researches or suitable candidates for preclinical studies are required for evaluation the effect of the GelMA@Ly-PRF hydrogel on bone regeneration. Conclusions This study demonstrated that the GelMA@Ly-PRF hydrogel had the potential to promote formation of new blood vessel and further repair rat calvarial defect. Ly-PRF had great potential to be uesd as a reservoir for sustainable supply various growth factors for tissue regeneration and GelMA hydrogel also had promising application in bone tissue engineering. Abbreviations Bone marrow mesenchymal stem cells Bone morphogenetic protein 2 Gelatin methacryloyl Human umbilical vein endothelial cells Insulin-like growth factor Lyophilized platelet-rich fibrin Methacrylic anhydride Phosphate buffer solution Platelet-derived growth factor Phosphate buffer solution Scanning electron microscope Transforming growth factor-β Vascular endothelial growth factor Author contributions HXJ, HB, ZJ and LMJ contributed to the conception and design of the project. HXJ, XSL, LCX, XXJ, THY, XYH, WJF, HZX and WJL prepared the original draft. HB and LMJ reviewed and edited the manuscript and supervised the study. All authors contributed to the article and approved the submitted version. Funding This study was supported by the Natural Science Foundation of Hunan Probince (Grant No. 2023JJ60373) and Hunan Provincial Natural Science Foundation (2025JJ81086). Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Compliance with ethical standards Conflict of interest The authors declare no competing interests. Ethics The study was reviewed and approved by the Ethics Committee of Nanhua Hospital, University of South China [2024-KY-012]. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Biao Hou, Email: 1045223533@qq.com. Jun Zhang, Email: zhangjuncq1215@163.com. Mingjiang Liu, Email: 15228449@qq.com. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.